Should I buy or sell Alignment Healthcare stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last twelve months. There are currently 1 sell rating, 4 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALHC shares. View ALHC analyst ratings or view top-rated stocks .

What is Alignment Healthcare's stock price target for 2024?

10 analysts have issued 12-month price objectives for Alignment Healthcare's shares. Their ALHC share price targets range from $4.50 to $12.00. On average, they expect the company's share price to reach $9.61 in the next twelve months. This suggests a possible upside of 94.2% from the stock's current price. View analysts price targets for ALHC or view top-rated stocks among Wall Street analysts .

How have ALHC shares performed in 2024?

Alignment Healthcare's stock was trading at $8.61 on January 1st, 2024. Since then, ALHC shares have decreased by 42.5% and is now trading at $4.95. View the best growth stocks for 2024 here .

Are investors shorting Alignment Healthcare?

Alignment Healthcare saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 3,940,000 shares, a decline of 17.6% from the March 15th total of 4,780,000 shares. Based on an average daily volume of 891,100 shares, the short-interest ratio is presently 4.4 days. Currently, 4.4% of the shares of the company are sold short. View Alignment Healthcare's Short Interest .

When is Alignment Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our ALHC earnings forecast .

How can I listen to Alignment Healthcare's earnings call?

Alignment Healthcare will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Alignment Healthcare's earnings last quarter?

Alignment Healthcare, Inc. (NASDAQ:ALHC) posted its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.03. The firm earned $465.39 million during the quarter, compared to analysts' expectations of $444.56 million. Alignment Healthcare had a negative trailing twelve-month return on equity of 75.64% and a negative net margin of 8.12%. The firm's revenue was up 28.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.31) EPS.

What guidance has Alignment Healthcare issued on next quarter's earnings?

Alignment Healthcare updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $590.0 million-$600.0 million, compared to the consensus revenue estimate of $550.8 million.

When did Alignment Healthcare IPO?

Alignment Healthcare (ALHC) raised $490 million in an IPO on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

How do I buy shares of Alignment Healthcare?

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ALHC

Alignment Healthcare (ALHC) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Free ALHC Stock Alerts

$5.12

+0.17 (+3.43%)

(As of 12:27 PM ET)

Compare

Today's Range: $4.90
▼
$5.27
50-Day Range: $4.47
▼
$6.92
52-Week Range: $4.46
▼
$9.20

Volume: 275,717 shs
Average Volume: 869,350 shs
Market Capitalization: $967.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $9.61

Get Alignment Healthcare alerts:

Alignment Healthcare MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 94.2% Upside
$9.61 Price Target
Short Interest: Healthy
4.38% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.56
Based on 5 Articles This Week
Insider Trading: Acquiring Shares
$496,460 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.59) to ($0.49) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.52 out of 5 stars

Medical Sector

235th out of 914 stocks

Hospital & Medical Service Plans Industry

7th out of 11 stocks

4.3

Analyst's Opinion

Consensus Rating
Alignment Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 4 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Alignment Healthcare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.0

Short Interest

Percentage of Shares Shorted
4.38% of the float of Alignment Healthcare has been sold short.
Short Interest Ratio / Days to Cover
Alignment Healthcare has a short interest ratio ("days to cover") of 4.4.
Change versus previous month
Short interest in Alignment Healthcare has recently decreased by 17.57%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Alignment Healthcare does not currently pay a dividend.
Dividend Growth
Alignment Healthcare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ALHC.

2.0

News and Social Media Coverage

News Sentiment
Alignment Healthcare has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Alignment Healthcare this week, compared to 3 articles on an average week.
Search Interest
Only 2 people have searched for ALHC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Alignment Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Alignment Healthcare insiders have bought 7.79% more of their company's stock than they have sold. Specifically, they have bought $496,460.00 in company stock and sold $460,587.00 in company stock.
Percentage Held by Insiders
Only 6.30% of the stock of Alignment Healthcare is held by insiders.
Percentage Held by Institutions
86.19% of the stock of Alignment Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Alignment Healthcare are expected to grow in the coming year, from ($0.59) to ($0.49) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Alignment Healthcare is -6.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Alignment Healthcare is -6.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Alignment Healthcare has a P/B Ratio of 5.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

About Alignment Healthcare Stock (NASDAQ:ALHC)

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

ALHC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ALHC Stock News Headlines

March 30, 2024 | insidertrades.com

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman Sells 4,299 Shares

March 22, 2024 | insidertrades.com

Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Dawn Christine Maroney Sells 15,861 Shares

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

March 19, 2024 | insidertrades.com

Insider Buying: Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO Buys 103,000 Shares of Stock

April 17, 2024 | investing.com

Alignment Healthcare LLC (ALHC)

April 16, 2024 | msn.com

UnitedHealth sends beaten-down peers higher after Q1 results

April 11, 2024 | msn.com

Fitch flags Medicare utilization trends ahead of managed care earnings

April 11, 2024 | globenewswire.com

Alignment Healthcare to Announce First Quarter 2024 Financial Results and Host Conference Call Thursday, May 2, 2024

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

April 4, 2024 | stockhouse.com

Alignment Health Recognized as One of America's Most Trustworthy Companies by Newsweek for Second Consecutive Year

March 23, 2024 | investing.com

Alignment healthcare CFO sells over $144k in company stock

March 23, 2024 | investing.com

Alignment Healthcare's chief legal officer sells over $126k in stock

March 21, 2024 | finance.yahoo.com

Insider Sell: President, Markets Dawn Maroney Sells 29,113 Shares of Alignment Healthcare Inc (ALHC)

March 21, 2024 | finance.yahoo.com

Insider Sell: Chief Legal and Admin. Officer Christopher Joyce Sells 25,060 Shares of Alignment ...

March 19, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

March 18, 2024 | finance.yahoo.com

ALHC Apr 2024 7.500 call

March 17, 2024 | uk.investing.com

Alignment Healthcare CIO sells shares worth over $23,000

March 17, 2024 | investing.com

Alignment Healthcare's chief experience officer sells shares worth over $21k

March 17, 2024 | investing.com

Alignment healthcare president sells over $105k in company stock

March 16, 2024 | finance.yahoo.com

ALHC Apr 2024 7.500 put

March 16, 2024 | finance.yahoo.com

Insider Sell: President, Markets Dawn Maroney Sells 21,537 Shares of Alignment Healthcare Inc (ALHC)

March 13, 2024 | markets.businessinsider.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claim On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

March 11, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

March 7, 2024 | globenewswire.com

Alignment Healthcare to Participate in a Virtual Fireside hosted by Raymond James

March 7, 2024 | businesswire.com

Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 6, 2024 | msn.com

Barclays cautious on Medicare as managed care coverage starts

March 6, 2024 | stockhouse.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

See More Headlines

Receive ALHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alignment Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/27/2024
Today: 4/18/2024
Next Earnings (Confirmed): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Hospital & medical service plans
Sub-Industry: N/A
Current Symbol: NASDAQ:ALHC
CUSIP: N/A
CIK: 1832466
Web: www.alignmenthealthcare.com
Phone: 844-310-2247
Fax: N/A
Employees: 1,536
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $9.61
High Stock Price Target: $12.00
Low Stock Price Target: $4.50
Potential Upside/Downside: +94.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.79)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-148,020,000.00
Net Margins: -8.12%
Pretax Margin: -8.13%
Return on Equity: -75.64%
Return on Assets: -20.36%

Debt

Debt-to-Equity Ratio: 1.02
Current Ratio: 1.84
Quick Ratio: 1.84

Sales & Book Value

Annual Sales: $1.82 billion
Price / Sales: 0.51
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.84 per share
Price / Book: 5.89

Miscellaneous

Outstanding Shares: 188,978,000
Free Float: 177,072,000
Market Cap: $935.44 million
Optionable: Optionable
Beta: 1.30

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. John E. Kao (Age 62)
Founder, President, CEO & Director
Comp: $1.63M
Mr. Robert Thomas Freeman (Age 34)
Chief Financial Officer
Comp: $948.74k
Ms. Dawn Christine Maroney (Age 57)
President of Health Markets & CEO of Health Plan
Comp: $1.12M
Dr. Donald S. Furman M.B.A. (Age 73)
M.D., Co-Founder & Chief Clinical Officer
Ms. Charlotte LeBlanc
Chief Accounting Officer and Senior Vice President
Mr. Robert L. Scavo (Age 58)
Chief Information Officer
Mr. Christopher J. Joyce (Age 60)
Chief Legal & Administrative Officer
Ms. Amanda Root
Chief Communications Officer
Mr. Andreas Wagner
Chief People Officer
Dr. Hyong J. Kim M.D. (Age 55)
Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ALHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Alignment Healthcare stock right now?: 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last twelve months. There are currently 1 sell rating, 4 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALHC shares.
View ALHC analyst ratings or view top-rated stocks.
What is Alignment Healthcare's stock price target for 2024?: 10 analysts have issued 12-month price objectives for Alignment Healthcare's shares. Their ALHC share price targets range from $4.50 to $12.00. On average, they expect the company's share price to reach $9.61 in the next twelve months. This suggests a possible upside of 94.2% from the stock's current price.
View analysts price targets for ALHC or view top-rated stocks among Wall Street analysts.
How have ALHC shares performed in 2024?: Alignment Healthcare's stock was trading at $8.61 on January 1st, 2024. Since then, ALHC shares have decreased by 42.5% and is now trading at $4.95.
View the best growth stocks for 2024 here.
Are investors shorting Alignment Healthcare?: Alignment Healthcare saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 3,940,000 shares, a decline of 17.6% from the March 15th total of 4,780,000 shares. Based on an average daily volume of 891,100 shares, the short-interest ratio is presently 4.4 days. Currently, 4.4% of the shares of the company are sold short.
View Alignment Healthcare's Short Interest.
When is Alignment Healthcare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ALHC earnings forecast.
How can I listen to Alignment Healthcare's earnings call?: Alignment Healthcare will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Alignment Healthcare's earnings last quarter?: Alignment Healthcare, Inc. (NASDAQ:ALHC) posted its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.03. The firm earned $465.39 million during the quarter, compared to analysts' expectations of $444.56 million. Alignment Healthcare had a negative trailing twelve-month return on equity of 75.64% and a negative net margin of 8.12%. The firm's revenue was up 28.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.31) EPS.
What guidance has Alignment Healthcare issued on next quarter's earnings?: Alignment Healthcare updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $590.0 million-$600.0 million, compared to the consensus revenue estimate of $550.8 million.
When did Alignment Healthcare IPO?: Alignment Healthcare (ALHC) raised $490 million in an IPO on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.
How do I buy shares of Alignment Healthcare?: Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ALHC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alignment Healthcare (ALHC) Stock Price, News & Analysis

Alignment Healthcare MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Alignment Healthcare Stock (NASDAQ:ALHC)

ALHC Stock Price History

ALHC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

ALHC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™